It interacts with the activating receptor DNAX-associated molecule-1 (DNAM-1 [or CD226]), primarily expressed on T cells, NK cells, B cells, and monocytes, promoting early tumor recognition and elimination (22, 23). The gene discussed is CD226; the disease is neoplasm.